Similarly, there is elevated GFAP‐positive astrogliosis in the grey matter of APOE4 AD patients compared to other APOE genotypes, and an overall greater astrogliosis between AD and age‐matched control cases 87. The gene discussed is GFAP; the disease is Alzheimer disease.